Advertisement

Topics

FDA Approves Tecentriq for People With Specific Type of Cancer

10:49 EDT 19 Oct 2016 | PharmPro

Genentech has announced that the FDA approved Tecentriq (atezolizumab) for the treatment of people with metastatic non-small cell lung cancer who have disease progression during or following platinum-containing chemotherapy,
Contributed Author: 
Genentech
Topics: 

Original Article: FDA Approves Tecentriq for People With Specific Type of Cancer

NEXT ARTICLE

More From BioPortfolio on "FDA Approves Tecentriq for People With Specific Type of Cancer"

Quick Search
Advertisement
 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Gilotrif (afatinib)
GILOTRIF (afatinib) is a kinase inhibitor indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L8...